HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch

Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill

During the weeklong stay by the Supreme Court to temporarily restore online access to the abortion pill mifepristone after a shock appeals court decision last Friday, scores of experts, industry heavyweights and former regulators have weighed in to defend the availability of the product.

By FiercePharma · May 9, 2026 · via FiercePharma
Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill

Image: FiercePharma

This is an aggregated industry headline. Read the full story at FiercePharma

Tags
policyformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Policy
All Policy →
Japan’s FY26 price revision expands G1 repricing and drives price reduction
PolicyPharmaceutical Technology ↗
Japan’s latest NHI drug price revision for FY26 has now come into effect, with an average 4.02% drop in prices…
May 8, 2026
A Look at the GENEROUS Model and Factors That Could Impact Medicaid Drug Costs
PolicyKFF Health News ↗
This issue brief provides background on the GENEROUS model, examines the factors that will contribute to the m…
May 8, 2026
STAT+: More political interference at the FDA?
PolicySTAT News ↗
A political appointee gets in the way of a Sanofi drug's approval, and more from STAT's D.C. Diagnosis newslet…
May 7, 2026